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Background and objective
Transcatheter arterial embolization is an alternative to surgical management when dealing with recurrent bleeding from a 
peptic ulcer after a failed endoscopic treatment. The purpose of this study is to analize the effectiveness and outcomes of 
transcatheter arterial embolization and identify the factors that influenced morbidity and mortality rates.
Materials and methods
A retrospective single-center analysis was performed of 20 patients who underwent transcatheter arterial embolization for 
acute upper gastrointestinal bleeding from gastroduodenal ulcers from 2012 to 2015 at the Republic Vilnius University Hos-
pital. We analyzed the association of early rebleeding and mortality with sex, age, number of units of blood components ad-
ministered to the patients, length of hospital stay, time passed until embolization, therapeutic or prophylactic embolization. 
Results
The embolization procedure had a technical success rate of a 100%. 14 (70%) were prophylactic embolizations and 6 (30%) 
were therapeutic embolizations. Three patients (15%) had an episode of rebleeding following embolization, 5 (25%) pa-
tients died. Patients that died received statistically significant larger number of blood components (p=0.04 for frozen plasma; 
p=0.01 for packed red blood cells) and patients that survived had a shorter hospital stay (p=0.05). No associations were ob-
served between rebleeding and factors analyzed.
Conclusions
Transcatheter arterial embolization is a feasible method for the treatment of rebleeding in gastroduodenal ulcer after en-
doscopic treatment, resulting in high rates of technical and clinical success and low complication rates. Further prospective 
randomized trials are needed to obtain more evidence.
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Įvadas
Transkateterinė arterinė embolizacija yra chirurginio gydymo alternatyva. Ji taikoma esant pakartotiniam kraujavimui 
iš skrandžio ar dvylikapirštės žarnos opos po nepavykusio kraujo stabdymo endoskopijos metu. Mes nagrinėjome 
transkateterinės embolizacijos efektyvumą, gydymo baigtis ir rodiklius, galinčius turėti įtakos sergamumui bei mirtingumui.
Metodai
Atlikome retrospektyviąją analizę, į kurią įtraukėme 20 pacientų, kuriems nuo 2012 m. iki 2015 m. Respublikinėje Vilniaus 
universitetinėje ligoninėje buvo atlikta transkateterinė arterinė embolizacija dėl ūminio kraujavimo iš viršutinės virškinamojo 
trakto dalies. Ieškojome ryšio tarp pakartotinio kraujavimo bei mirštamumo ir pacientų lyties, amžiaus, perpiltų kraujo 
komponentų vienetų, hospitalizacijos trukmės, laiko iki embolizacijos, atliktos embolizacijos rūšies (profilaktinė ar terapinė).
Rezultatai
Embolizacijos techninis efektyvumas buvo 100 %. Keturiolikai pacientų (70 %) buvo atlikta profilaktinė ir 6 (30 %) – terapinė 
embolizacija. Trims (15 %) pacientams po embolizacijos pasikartojo kraujavimas. Penki (25 %) pacientai mirė. Pacientams, ku-
rie vėliau mirė, buvo perpilta statistiškai reikšmingai daugiau kraujo komponentų vienetų (šviežiai šaldytos plazmos p=0,04; 
eritrocitų masės p=0,01), jų hospitalizacija buvo ilgesnė (p=0,05). Statistiškai reikšmingų veiksnių, galinčių turėti įtakos pakar-
totinio kraujavimo dažniui, neradome.
Išvados
Transkateterinė arterinė embolizacija yra tinkamas metodas po endoskopinio gydymo pasikartojusiam kraujavimui iš 
skrandžio ar dvylikapirštės žarnos opų gydyti. Nors šis būdas pasižymi dideliu techniniu ir klinikiniu efektyvumu ir mažu 
komplikacijų dažniu, tačiau reikalingi tolesni atsitiktinių imčių tyrimai šio gydymo būdo tinkamumui pagrįsti.
Reikšminiai žodžiai: peptinės opos, kraujavimas, transkateterinė arterinė embolizacija
Introduction
Peptic ulcer disease is a common condition with a yearly 
incidence of more than 5 cases per 1000 persons [1] 
and bleeding occurs in as many as 15% of them [2]. It 
remains a medical emergency problem worldwide – up 
to 59% of nonvariceal acute gastrointestinal bleeding 
is attributed to bleeding from a peptic ulcer [1, 2]. 
The hospitalization rate for peptic ulcer disease de-
creased 35% from 71.1/100,000 in 1998 population 
to 46/100,000 population in 2010. Despite the wide 
usage of H2 receptor antagonists, proton pump inhibi-
tors and antibiotic eradication of H. pylori, peptic ulcer 
bleeding remains a major problem with high mortality 
rates among the elderly patients – 20-30 deaths per 100 
000 patients over the age of 65 years [3–5]. The main 
risk factors for peptic ulcer bleeding are non-steroidal 
anti-inflammatory drugs usage and comorbidities such 
as hepatic, renal or malignant diseases [6–8]. The initial 
treatment of choice in case of peptic ulcer bleeding 
alongside pharmacotherapy is endoscopic hemostasis, 
which significantly decreases rebleeding rates and mor-
tality [9]. Endoscopy helps confirming the diagnosis 
and provides initial hemostasis options – epinephrine 
injections alongside clips, glue, coagulation or sclerosant 
injection [9–11]. If the first endoscopy is not successful, 
repeat endoscopic treatment is recommended, according 
to NICE guidelines [12]. However recurrent bleeding 
occurs in 5-10% [13, 14]. In such cases surgery was tra-
ditionally the treatment of choice, however, if expertise 
is available, NICE guidelines also recommend arterial 
embolization as an alternative to surgical treatment [15]. 
In 1972 Rosch et al. presented selective transcatheter 
arterial embolization for upper gastrointestinal bleeding 
control and since then it has been used successfully as 
an alternative to surgery in selected groups of patients 
[16–18]. Controversy remains regarding the gastroduo-
denal ulcers bleeding treatment algorithm.
Our purpose was to analize the effectiveness and 
outcomes of transcatheter arterial embolization and 
identify the clinical and technical factors that influenced 
the outcome of transcatheter arterial embolization and 
quantify the impact of those variables on morbidity and 
mortality rates.
Materials and methods
We performed a retrospective analysis of 20 patients 
who underwent transcatheter arterial embolization for 
acute upper gastrointestinal bleeding from gastroduo-
denal ulcers from 2012 November to 2015 November 
at the Republic Vilnius University Hospital. All of the 
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patients after endoscopy and confirmation of diagnosis 
were classified according to Forrest classification and 
administered conservative treatment upon arrival – 
intravenous bolus injection of proton-pump inhibitor 
(80  mg Omeprazol) and 40mg Omeprazol intrave-
nously three times per day for three days. Patients with 
coagulation disorders had their coagulopathy corrected.
All of the 20 patients had shown clinical signs of 
rebleeding after initial endoscopic treatment (blood 
from nasogastric tube, low blood pressure, increase in 
pulse, low hemoglobin count) despite initial conserva-
tive medical therapy and local endoscopic treatment 
with adrenaline (1:10 000) injections. All angiographic 
procedures were performed with standard percutaneous 
transfemoral catheterization. Selective angiography of 
the celiac trunk, gastroduodenal artery and superior 
mesenteric artery was obtained using a 5-Fr catheter. 
Embolization performed after visualization of Ultravist 
contrast extravasation at angiography was referred to 
as “therapeutic embolization”. When visualization of 
contrast extravasation on angiography was not seen, 
“prophylactic embolization” was performed. Emboli-
zation was carried out by placing various types of vas-
cular VortX coils and no embolic agents other than coils 
were used. If the bleeding ulcer was in the fundus or 
corpus of the stomach, then the left gastric artery (LGA) 
was selectively embolized. If the bleeding ulcer was in 
the stomach antrum or duodenum, the gastroduodenal 
artery (GDA) was selectively embolized on both sides of 
the bleeding site to prevent ‘back-door’ effect – repeated 
bleeding related with retrograde perfusion. Postemboli-
zation angiography was performed to confirm the effect 
of embolization in all of the patients.
Demographic variables, clinical findings, endoscopic 
treatment, transfusion requirements before and after 
transcatheter arterial embolization, length of hospital 
stay, and outcomes including recurrent bleeding, need 
for surgery after transcatheter arterial embolization, and 
in-hospital death were recorded.
We analyzed the association between early rebleeding 
and following factors: sex, age, number of units of blood 
components administered to the patients, length of hos-
pital stay, time passed until embolization and whether 
the embolization performed was therapeutic or empi-
rical. Analysis was also carried out between mortality 
following embolization and factors mentioned above. 
Pearson‘s chi-square test was used to test for association 
between categorical data and Independent-samples t-
test for continuous variables. Data processing was done 
using SPSS 20.0 software.
Results
Transarterial embolization was performed to twenty 
patients, 14 (70%) male and 6 (30%) female. The mean 
age of the patients was 65.6 (±17.13) years, ranging 
from 30 to 93 years. There was a mean time of 3.11 
(±1.99) days, ranging from 0.8 to 8 days, that passed 
since the first symptoms of bleeding began to the time 
that embolization was performed. 
There was an average of 8.35 (±4.21) units of packed 
red blood cells administered to the patients prior to 
embolization procedure. The mean of packed red cells 
received in total during the period patient was hospitali-
zed was 11.90 (±5.35) units. An average of 6.20 (±5.85) 
units of frozen plasma was received by patients during 
transfusion procedures. Summary of patients characte-
ristics are shown in Table 1.
In 5 (25.0%) of the 20 patients the cause of he-
morrhage was determined to be a bleeding gastric ulcer 
(two from fundus et corpus, three from antrum) and 
in 15 (75.0%) patients bleeding was originating from a 
duodenal ulcer. The data of ulcers location and Forrest 
classification is summarised in Table 2.
In 18 (90%) cases site of the embolization was the 
gastroduodenal artery. The left gastric artery was targe-
ted in two (10%) cases. 
The embolization procedure had a technical success 
rate of a 100%. Of the 20 embolizations performed 14 
(70%) were prophylactic embolizations and 6 (30%) 
were therapeutic embolizations, when bleeding site was 
visualized before embolization using angiography. Du-
ring the procedure there were no complications. There 
were no gastrointestinal tract ischaemic complications 
in 30 days period. Procedural outcomes are shown in 
Table 3.
The average hospital stay after the embolization 
procedure was 14.90 (±9.78) days. 17 patients had no 
rebleeding within 30 days. Three patients (15%) had an 
episode of repeated bleeding. All three of these patients 
had a prophylactic embolizations. Two of these cases 
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Table 1. Summary of patients characteristics
Parameter Mean  ±SD
Mean age (years) 65.6 ±17.13
Transfusion requirement 
     Mean units of packed red cells (total) 11.90 ±5.35
     Mean units of packed red cells before TAE 8.35 ±4.21
     Mean units of frozen plasma 6.20 ±5.85
Mean time from bleeding to TAE (days) 3.11 ±1.99
Mean days of hospitalization 14.9 ±9.78
Table 2. Forrest classification of peptic ulcers at primary endoscopy
Grade N (%) Gastric ulcer (%) Duodenal ulcer (%)
Forrest IA 3 (15%) 0 (0%) 3 (15%)
Forrest IB 5 (25%) 1 (5%) 4 (20%)
Forrest IIA 5 (25%) 1 (5%) 4 (20%)
Forrest IIB 5 (25%) 2 (10%) 3 (15%)
Forrest IIC 1 (5%) 0 (0%) 1 (5%)
Forrest III 1 (5%) 1 (5%) 0 (0%)
Total 20 (100%) 5 (25%) 15 (75%)
Table 3. Procedural outcomes
Outcome N (%) 
Embolization 20 100.0%
     Prophylactic embolization 14 70.0%
     Therapeutic embolization 6 30.0%
Technical success 20 100.0%
Rebleeding 3 15.0%
Complications 0 0.0%
Table 4. Factors associated with mortality
Factor Died (Mean ±SD)
Survived
(Mean ±SD) t-test value P value
Hospital stay 22.6 ±17.47 12.33 ±3.77 2.24 0.05
Units of frozen plasma 11.80 ±9.41 4.33 ±2.47 2.92 0.04
Units of packed red blood cells 17.00±4.85 10.20±4.44 2.90 0.01
were treated surgically and one patient had a repeated 
endoscopic treatment. 5 (25%) of the 20 patients, died 
from the reasons not related with non-stopped bleeding: 
from acute respiratory failure (n=3) multiple organ 
failure (n=1), sepsis (n=1). All five patients had a pro-
phylactic embolization. The mean age of patients that 
died was 58.6 years. One of these patients underwent a 
surgical procedure for bleeding control, 4 had more than 
one additional diseases.
There was no statistically significant association of 
repeated bleeding and patient sex, age, time passed 
until hospitalization, therapeutic or prophylactic em-
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tions [26]. Among the specific complications are bowel 
ischemia (0–16%) and duodenal stenosis (0–25%), 
which are rare because of the rich collateral blood supply 
of the targeted region [27, 28]. Unintentional hepatic 
artery embolization can cause liver failure, however this 
is more common for patients with liver cirrhosis [29]. 
In our study no specific complications were detected in 
30 days period. 
During thirty days period following embolization, 
three (15%) of our patients had an episode of repeated 
bleeding. The rate of rebleeding is lower than that re-
ported by Loffroy et al. in their review of embolization 
for non-variceal upper gastrointestinal bleeding (33%) 
or the rate reported in literature review of embolization 
for gastroduodenal ulcer treatment (25%) [28, 30]. 
Coagulation disorders, larger number of blood compo-
nents transfused, a longer time from the beginning of 
shock to the procedure, previous surgery for bleeding, 
corticosteroid intake and multiple comorbidities are 
among the factors shown to have a negative effect on 
the bleeding rates following arterial embolization [28, 
30, 31]. We did not find any statistically significant as-
sociations between the factors analyzed and rebleeding 
in our cohort which could be attributed to a small pa-
tient base or that our retrospective study design did not 
allow us to accurately check for specific comorbidities 
or coagulation disorders. 
The thirty day mortality was 25% in our patients, 
which is the same as reported in review by Loffroy et al. 
(25%) [30]. Among the factors that are known to effect 
the outcome of embolization therapy are advanced age, 
concomitant illnesses such as hepatic, renal or malignant 
diseases or massive blood transfusions [8, 28]. The mean 
age of our patients was 65.6 years which does not dif-
fer from the mean age presented in a recent literature 
review by Loffroy et al. (65 years) [28]. Such advanced 
age of the patients may be explained by the fact that 
embolization is often reserved for older patients who 
would be at a high risk for surgery [18]. The mean time 
that passed between the onset of symptoms and embo-
lization of 3.11 days was longer than that reported by 
Loffroy et al. in their experience (2.3 days), however this 
did not prove to be a factor associated with rebleeding 
or mortality rates in our study. An association was also 
observed between the need of transfusions and thirty 
bolization or number of units of blood transfused. 
Statistically significant differences were found between 
mortality and total number of units of packet red cells 
and frozen plasma administered to patients during their 
hospital stay – patients that died received a larger num-
ber of blood components. There was also a difference 
between the length of hospital stay – patients that sur-
vived had a shorter hospital stay. We found differences 
between mortality in female and male, therapeutic and 
prophylactic embolization, but not statistically signifi-
cant (p= 0.09).
Discussion
The modality of choice for diagnosis and treatment of 
acute bleeding originating from a peptic ulcer is endos-
copy. It provides options to stop the bleeding and has 
been shown to decrease rebleeding rates and mortality 
when used alongside proton pump inhibitors [19, 20]. 
However in some cases endoscopy fails to provide ad-
equate hemostasis. The rate of such rebleeding after ini-
tial endoscopy has not been significantly decreasing in 
the last years and remains 8–10% [21]. Salvage therapies 
such as surgery or more recently – transcatheter arterial 
embolization have been used to control severe bleeding 
that does not respond to endoscopy. For cases where 
bleeding persists after a successful initial endoscopy, 
repeat endoscopy is the recommended method [14]. A 
randomized control trial compared repeat endoscopic 
treatment with surgery and found that surgery group 
had more postoperative complications; however such 
factors as ulcer size or hemodynamic instability lead 
to an unsuccessful endoscopic hemostasis [13]. Several 
studies have compared angiographic embolization and 
surgery over the years [18, 22, 23]. Angiographic embo-
lization was associated with reduced treatment-related 
complications (20–54% vs 37–68%), but recurrent 
bleeding (RR 2, 95% CI 1.3–2.9) was more often after 
embolization [21]. A recent systematic review found no 
differences in mortality when comparing both of these 
methods [24]. Because it is less invasive as surgery and 
has a lower complication rate, arterial embolization is 
often reserved for high surgical risk patients [18, 25].
The complications of embolization are groin hema-
tomas or acute renal failure, both of which are observed 
with the same rate as in other endovascular interven-
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days mortality. Similar factor association of massive 
blood loss and mortality has been reported by Larson et 
al. in their 115 patient series on upper gastrointestinal 
bleeding outcomes [34]. 
We observed differences in the outcome whether the 
source of the bleeding was visualized during angiog-
raphy prior to embolization and thirty days mortality 
rates – no patients died in the therapeutic embolization 
group and 35.7% mortality was seen in the prophylactic 
embolization group. The difference comparing mortal-
ity was not statistically significant however, most likely 
due to our small patient base of twenty patients. Several 
other series report no difference in outcome between 
patients in the prophylactic embolization group and 
patients who had the source of the bleeding visualized 
prior to embolization [29, 32]. One explanation may be 
the abundant collateral circulation which continues to 
supply blood to the bleeding site [28, 32]. The approach 
we took to avoid possible retrograde bleeding was to use 
the ‘sandwich’ technique on the gastroduodenal artery 
during embolization, which should prevent additional 
bleeding from the superior mesenteric artery circulation. 
The technical success rate was 100% in our patients 
and the clinical success rate was 80%. Such results fit 
well in the success rates published by other authors 
(91–100% technical success rate and 63–100% clinical 
success rate) [17, 32]. The high rates of both technical 
and clinical success and many studies confirming the 
results of the feasibility of arterial embolization as a 
method for treatment of endoscopically unmanageable 
peptic ulcer bleeding has led to accepting embolization 
as the salvage treatment of choice after a failed em-
bolization. Furthermore, a recent studies have shown 
significant results while examining the role of transcath-
eter arterial embolization for prophylactic treatment 
of peptic ulcer bleeding after a successful endoscopy 
managed to stop the bleeding [35]. In patients with a 
high risk of rebleeding, this method reduced the rates of 
repeated bleeding episodes and the need for emergency 
surgery. Further studies on this approach are awaited 
to compare it with surgical treatment and endoscopic 
alternatives.  
To conclude, transcatheter arterial embolization is a 
feasible method for the treatment of endoscopically un-
manageable peptic ulcer bleeding, resulting in high rates 
of technical and clinical success and low complication 
rate. Further randomized prospective trials are needed 
to obtain more evidence and information.
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